Ali J. Haidar, Angela Chen, Judy L. Chen, Saba Al-Hashimi, Reza S. Ghaffari, S. Fung, Jordyn Silverstein, Gottfried E. Konecny, Edmund Tsui
This case series describes the management and outcomes of ocular toxic effects associated with mirvetuximab soravtansine therapy in female patients with folate receptor α–positive gynecologic malignant neoplasms.